LncRNA evf‐2 Exacerbates Podocyte Injury in Diabetic Nephropathy by Inducing Cell Cycle Re‐entry and Inflammation Through Distinct Mechanisms Triggered by hnRNPU
2024

LncRNA evf-2 and Podocyte Injury in Diabetic Nephropathy

Sample size: 9 publication 10 minutes Evidence: high

Author Information

Author(s): Zhang Chaojie, Zhao Hui, Yan Yufan, Li Yanfei, Lei Min, Liu Yong, Yang Longhua, Zhao Huijian, Zhou Sijie, Pan Shaokang, Liu Zhangsuo, Guo Jia

Primary Institution: Nephrology Research Center, the First Affiliated Hospital of Zhengzhou University

Hypothesis

LncRNA evf-2 exacerbates podocyte injury in diabetic nephropathy by inducing cell cycle re-entry and inflammation through distinct mechanisms triggered by hnRNPU.

Conclusion

The study reveals that lncRNA evf-2 plays a crucial role in podocyte injury in diabetic nephropathy, suggesting it as a potential target for gene therapy.

Supporting Evidence

  • lncRNA evf-2 is upregulated in podocytes of diabetic nephropathy patients.
  • Knockdown of lncRNA evf-2 alleviated podocyte injury in diabetic mice.
  • RNA sequencing revealed upregulation of mRNAs in cell cycle and inflammation pathways.
  • Chromatin isolation by RNA purification-mass spectrometry analysis highlighted hnRNPU as the main binding partner of evf-2.

Takeaway

This study found that a molecule called lncRNA evf-2 can make kidney cells called podocytes hurt more when someone has diabetes, which could help doctors find new ways to treat kidney problems.

Methodology

The study used RNA sequencing, immunohistochemistry, and various mouse models to investigate the role of lncRNA evf-2 in podocyte injury.

Limitations

The study primarily focuses on the role of lncRNA evf-2 without exploring other potential factors involved in podocyte injury.

Participant Demographics

The study included renal biopsy samples from 3 diabetic nephropathy patients, 3 diabetes mellitus patients, and 3 normal controls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/advs.202406532

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication